PRVA insider sale notice: David Mountcastle Form 144

David Mountcastle reported proposed sales of Common stock under a Form 144 filing.

Rhea-AI Filing Summary

David Mountcastle reported proposed sales of Common stock under a Form 144 filing.

The filing lists four option-originated Common share lots associated with option grant dates 08/28/2018 (3428 shares), 03/20/2019 (2699 shares), 12/04/2019 (998 shares), and 09/08/2020 (572 shares), each noted with a 02/27/2026 transaction date and labeled Cash.

The filing also discloses actual Common stock sales by David Mountcastle during the past three months: 23,887 shares sold on 12/12/2025 for $597,793.14 and 5,361 shares sold on 02/26/2026 for $134,030.87.

Insights

Compliance & Corporate Securities Counsel

Routine Form 144 notice of proposed/resolved insider sales; contains recent sale amounts and option-derived share lots.

The filing lists proposed sales tied to option exercises dated 08/28/2018, 03/20/2019, 12/04/2019, and 09/08/2020 with share counts 3428, 2699, 998, and 572 respectively and a transaction date of 02/27/2026. It also records completed open-market sales of 23,887 shares on 12/12/2025 and 5,361 shares on 02/26/2026.

These entries are procedural disclosures under resale rules; cash‑flow treatment and whether all listed option shares will be sold are not specified in the excerpt. Subsequent filings or broker confirmations would show final settlement and any remaining holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PRVA's Form 144 filing show about David Mountcastle?

The filing reports proposed sales of Common stock and prior sales. It lists option-derived lots of 3428, 2699, 998, and 572 shares dated 02/27/2026, and prior open-market sales of 23,887 and 5,361 shares.

How many PRVA shares did David Mountcastle sell in the past three months?

He sold 23,887 shares on 12/12/2025 for $597,793.14 and 5,361 shares on 02/26/2026 for $134,030.87, as shown in the filing.

Which option grant dates are associated with the shares listed in the PRVA Form 144?

The filing ties listed share lots to option grant dates 08/28/2018 (3428), 03/20/2019 (2699), 12/04/2019 (998), and 09/08/2020 (572), each shown with a 02/27/2026 transaction date.

Does the Form 144 state how sale proceeds will be used?

The excerpt shows sales labeled Cash and lists proceeds for prior transactions, but it does not state any use of proceeds or beneficiary; the filing records sale amounts only.

Is the Form 144 filing specific to NASDAQ-listed Common shares of PRVA?

Yes, the filing references Common shares trading on NASDAQ and lists the brokerage Fidelity Brokerage Services LLC as an intermediary for the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7697	192798.13	123688289	02/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Option Granted 08/28/2018	Issuer			3428	02/27/2026	Cash
Common	02/27/2026	Option Granted 12/04/2019	Issuer			998	02/27/2026	Cash
Common	02/27/2026	Option Granted 03/20/2019	Issuer			2699	02/27/2026	Cash
Common	02/27/2026	Option Granted 09/08/2020	Issuer			572	02/27/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	12/12/2025	23887	597793.14
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/26/2026	5361	134030.87

144: Remarks and Signature

Remarks
Date of Notice	02/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)